Meet Your ETF AI Analyst
- Discover how TipRanks' ETF AI Analyst can help you make smarter investment decisions
- Explore ETFs TipRanks' users love and see what insights the ETF AI Analyst reveals about the ones you follow.
An update from Aurora Cannabis ( (TSE:ACB) ) is now available.
Aurora Cannabis Inc. has released its interim financial statements for the three months ended June 30, 2025, showing a net revenue increase to $98.023 million from $83.435 million in the same period in 2024. This financial update indicates a positive trend in the company’s revenue, which could enhance its market position and stakeholder confidence.
The most recent analyst rating on (TSE:ACB) stock is a Hold with a C$8.50 price target. To see the full list of analyst forecasts on Aurora Cannabis stock, see the TSE:ACB Stock Forecast page.
Spark’s Take on TSE:ACB Stock
According to Spark, TipRanks’ AI Analyst, TSE:ACB is a Neutral.
Aurora Cannabis shows promising international growth and improved financial metrics, driven by a strategic focus on high-margin medical cannabis. However, challenges such as high valuation, inconsistent revenue, and cash flow issues weigh down the overall score.
To see Spark’s full report on TSE:ACB stock, click here.
More about Aurora Cannabis
Aurora Cannabis Inc. is a Canadian company operating in the cannabis industry, focusing on the production and distribution of medical and recreational cannabis products.
Average Trading Volume: 464,144
Technical Sentiment Signal: Strong Sell
Current Market Cap: C$347M
For a thorough assessment of ACB stock, go to TipRanks’ Stock Analysis page.